{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:12:12Z","timestamp":1791389532389,"version":"4.3.3"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":335,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1124\/jpet.123.001666","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T18:05:15Z","timestamp":1701367515000},"page":"613-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacologic Inhibition of Transient Receptor Potential Ion Channel Ankyrin 1 Counteracts 2-Chlorobenzalmalononitrile Tear Gas Agent\u2013Induced Cutaneous Injuries"],"prefix":"10.1016","volume":"388","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7121-5445","authenticated-orcid":false,"given":"Satyanarayana","family":"Achanta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendranath Reddy","family":"Chintagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrilatha","family":"Balakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Eric","family":"Jordt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001666_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.toxlet.2018.03.007","article-title":"TRPA1 and CGRP antagonists counteract vesicant-induced skin injury and inflammation","volume":"293","author":"Achanta","year":"2018","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.123.001666_bib600","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.taap.2017.03.007","article-title":"TRPA1: Acrolein meets its target","volume":"324","author":"Achanta","year":"2017","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.123.001666_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/nyas.14472","article-title":"Transient receptor potential channels in pulmonary chemical injuries and as countermeasure targets","volume":"1480","author":"Achanta","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.123.001666_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.burns.2008.06.007","article-title":"CS gas\u2013completely safe? A burn case report and literature review","volume":"35","author":"Agrawal","year":"2009","journal-title":"Burns"},{"key":"10.1124\/jpet.123.001666_bib4","doi-asserted-by":"crossref","first-page":"f3801","DOI":"10.1136\/bmj.f3801","article-title":"Tear gas is a chemical weapon, and Turkey should not use it to torture civilians","volume":"346","author":"Aktan","year":"2013","journal-title":"BMJ"},{"key":"10.1124\/jpet.123.001666_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/963638","article-title":"Long term effects of tear gases on respiratory system: analysis of 93 cases","volume":"2014","author":"Arbak","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1124\/jpet.123.001666_bib6","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/jid.2009.58","article-title":"Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin","volume":"129","author":"Atoyan","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.123.001666_bib7","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201637","article-title":"A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment","volume":"218","author":"Balestrini","year":"2021","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.123.001666_bib8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cell.2006.02.023","article-title":"TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents","volume":"124","author":"Bautista","year":"2006","journal-title":"Cell"},{"key":"10.1124\/jpet.123.001666_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-030212-183811","article-title":"TRPA1: a gatekeeper for inflammation","volume":"75","author":"Bautista","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/jpet.123.001666_bib10","first-page":"360","article-title":"Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control","volume":"23","author":"Bessac","year":"2008","journal-title":"Physiology (Bethesda)"},{"key":"10.1124\/jpet.123.001666_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1513\/pats.201001-004SM","article-title":"Sensory detection and responses to toxic gases: mechanisms, health effects, and countermeasures","volume":"7","author":"Bessac","year":"2010","journal-title":"Proc Am Thorac Soc"},{"key":"10.1124\/jpet.123.001666_bib12","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1096\/fj.08-117812","article-title":"Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases","volume":"23","author":"Bessac","year":"2009","journal-title":"FASEB J"},{"key":"10.1124\/jpet.123.001666_bib13","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1172\/JCI34192","article-title":"TRPA1 is a major oxidant sensor in murine airway sensory neurons","volume":"118","author":"Bessac","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.123.001666_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-0536.2011.01989.x","article-title":"Investigating contact allergy to CS spray","volume":"66","author":"Bhargava","year":"2012","journal-title":"Contact Dermat"},{"key":"10.1124\/jpet.123.001666_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00139709-200322020-00005","article-title":"Tear gases and irritant incapacitants. 1-chloroacetophenone, 2-chlorobenzylidene malononitrile and dibenz[b,f]-1,4-oxazepine","volume":"22","author":"Blain","year":"2003","journal-title":"Toxicol Rev"},{"key":"10.1124\/jpet.123.001666_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.taap.2008.04.005","article-title":"Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor","volume":"231","author":"Br\u00f4ne","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.123.001666_bib17","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0900591106","article-title":"A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma","volume":"106","author":"Caceres","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.001666_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bph.13760","article-title":"Transient receptor potential cation channel subfamily M member 8 channels mediate the anti-inflammatory effects of eucalyptol","volume":"174","author":"Caceres","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001666_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.toxlet.2018.04.015","article-title":"In vitro human skin permeation and decontamination of 2-chloroethyl ethyl sulfide (CEES) using Dermal Decontamination Gel (DDGel) and Reactive Skin Decontamination Lotion (RSDL)","volume":"291","author":"Cao","year":"2018","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.123.001666_bib20","doi-asserted-by":"crossref","first-page":"b2283","DOI":"10.1136\/bmj.b2283","article-title":"Management of the effects of exposure to tear gas","volume":"338","author":"Carron","year":"2009","journal-title":"BMJ"},{"key":"10.1124\/jpet.123.001666_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/13543776.2020.1797679","article-title":"Transient receptor potential ankyrin 1 (TRPA1) antagonists: a patent review (2015-2019)","volume":"30","author":"Chen","year":"2020","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/jpet.123.001666_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.pain.2011.01.049","article-title":"Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation","volume":"152","author":"Chen","year":"2011","journal-title":"Pain"},{"key":"10.1124\/jpet.123.001666_bib23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/226890a0","article-title":"CS gas: infringing the gas laws","volume":"226","year":"1970","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001666_bib24","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI30951","article-title":"Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain","volume":"117","author":"Dai","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.123.001666_bib25","doi-asserted-by":"crossref","first-page":"24136","DOI":"10.1074\/jbc.M710280200","article-title":"TRPA1 mediates the noxious effects of natural sesquiterpene deterrents","volume":"283","author":"Escalera","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.123.001666_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.toxlet.2020.07.001","article-title":"In vitro decontamination efficacy of the RSDL\u00ae (Reactive Skin Decontamination Lotion Kit) lotion component against riot control agents: capsaicin, Mace\u2122 (CN) and CS","volume":"332","author":"Gebremedhin","year":"2020","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.123.001666_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpha.2019.12.005","article-title":"Analysis of TRPA1 antagonist, A-967079, in plasma using high-performance liquid chromatography tandem mass-spectrometry","volume":"10","author":"Gyamfi","year":"2020","journal-title":"J Pharm Anal"},{"key":"10.1124\/jpet.123.001666_bib28","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1111\/bph.12723","article-title":"The pharmacology of TRP channels","volume":"171","author":"Holzer","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001666_bib29","first-page":"18","article-title":"Evaluation of CS (o-chlorobenzylidene malononitrile) concentrations during U.S. Army mask confidence training","volume":"74","author":"Hout","year":"2011","journal-title":"J Environ Health"},{"key":"10.1124\/jpet.123.001666_bib30","doi-asserted-by":"crossref","first-page":"e738","DOI":"10.1097\/j.pain.0000000000002470","article-title":"Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function","volume":"163","author":"Jain","year":"2022","journal-title":"Pain"},{"key":"10.1124\/jpet.123.001666_bib31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(96)91454-3","article-title":"CS sprays: antidote and decontaminant","volume":"347","author":"Jones","year":"1996","journal-title":"Lancet"},{"key":"10.1124\/jpet.123.001666_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-cellbio-101011-155833","article-title":"TRP channels and pain","volume":"29","author":"Julius","year":"2013","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1124\/jpet.123.001666_bib33","doi-asserted-by":"crossref","first-page":"c1189","DOI":"10.1136\/bmj.c1189","article-title":"Guidance needed on secondary effects of CS gas on staff","volume":"340","author":"Kain","year":"2010","journal-title":"BMJ"},{"key":"10.1124\/jpet.123.001666_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/014107680309600404","article-title":"Short-term and long-term physical effects of exposure to CS spray","volume":"96","author":"Karagama","year":"2003","journal-title":"J R Soc Med"},{"key":"10.1124\/jpet.123.001666_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00405-008-0653-5","article-title":"Acute laryngeal and bronchial obstruction after CS (o-chlorobenzylidenemalononitrile) gas inhalation","volume":"266","author":"Karaman","year":"2009","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1124\/jpet.123.001666_bib36","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/S0140-6736(20)31560-9","article-title":"Allergic contact dermatitis and tracheobronchitis associated with repeated exposure to tear gas","volume":"396","author":"Lam","year":"2020","journal-title":"Lancet"},{"key":"10.1124\/jpet.123.001666_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916677761","article-title":"Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory- and neuropathic-induced mechanical hypersensitivity in rats","volume":"12","author":"Lehto","year":"2016","journal-title":"Mol Pain"},{"key":"10.1124\/jpet.123.001666_bib38","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1096\/fj.13-229948","article-title":"TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis","volume":"27","author":"Liu","year":"2013","journal-title":"FASEB J"},{"key":"10.1124\/jpet.123.001666_bib39","article-title":"Oxidized phospholipid oxPAPC activates TRPA1 and contributes to chronic inflammatory pain in mice","volume":"11","author":"Liu","year":"2016","journal-title":"pLoS One"},{"key":"10.1124\/jpet.123.001666_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jemermed.2007.01.015","article-title":"Response to \u201cPrevention of CS \u2018tear gas\u2019 eye and skin effects and active decontamination with Diphoterine: preliminary studies in 5 French gendarmes\u201d","volume":"32","author":"Luka","year":"2007","journal-title":"J Emerg Med"},{"key":"10.1124\/jpet.123.001666_bib41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature05544","article-title":"Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines","volume":"445","author":"Macpherson","year":"2007","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001666_bib42","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.3390\/ijms22063065","article-title":"The role of TRPA1 in skin physiology and pathology","volume":"22","author":"Maglie","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.123.001666_bib43","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1021\/acs.jmedchem.2c01830","article-title":"Discovery of BAY-390, a selective CNS penetrant chemical probe as transient receptor potential ankyrin 1 (TRPA1) antagonist","volume":"66","author":"Mesch","year":"2023","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001666_bib44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jat.767","article-title":"Riot control agents: pharmacology, toxicology, biochemistry and chemistry","volume":"21","author":"Olajos","year":"2001","journal-title":"J Appl Toxicol"},{"key":"10.1124\/jpet.123.001666_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/1876386301306010137","article-title":"Roles of TRPA1 in pain pathophysiology and implications for the development of a new class of analgesic drugs","volume":"6","author":"Radresa","year":"2013","journal-title":"Open Pain J"},{"key":"10.1124\/jpet.123.001666_bib46","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0277-9536(02)00127-2","article-title":"Health and safety in policing: lessons from the regulation of CS sprays in the UK","volume":"56","author":"Rappert","year":"2003","journal-title":"Soc Sci Med"},{"key":"10.1124\/jpet.123.001666_bib500","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/nyas.13141","article-title":"Tear gas: an epidemiological and mechanistic reassessment","volume":"1378","author":"Rothenberg","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.123.001666_bib47","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1021\/acs.jmedchem.6b00039","article-title":"Optimization of a novel quinazolinone-based series of transient receptor potential A1 (TRPA1) antagonists demonstrating potent in vivo activity","volume":"59","author":"Schenkel","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001666_bib48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jramc-2013-000165","article-title":"Riot control agents: the tear gases CN, CS and OC\u2013a medical review","volume":"161","author":"Schep","year":"2015","journal-title":"J R Army Med Corps"},{"key":"10.1124\/jpet.123.001666_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/emj.2009.084921","article-title":"Allergic contact dermatitis due to CS spray","volume":"28","author":"Shambhu","year":"2011","journal-title":"Emerg Med J"},{"key":"10.1124\/jpet.123.001666_bib50","first-page":"219","article-title":"The new scoring system for evaluation of skin inflammation extent and severity in patients with atopic dermatitis","volume":"13","author":"Silny","year":"2005","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1124\/jpet.123.001666_bib51","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/bs.pmch.2016.11.003","article-title":"Recent progress in the discovery and development of TRPA1 modulators","volume":"56","author":"Skerratt","year":"2017","journal-title":"Prog Med Chem"},{"key":"10.1124\/jpet.123.001666_bib52","first-page":"595","article-title":"The use of chemical incapacitant sprays: a review","volume":"52","author":"Smith","year":"2002","journal-title":"J Trauma"},{"key":"10.1124\/jpet.123.001666_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/002580240104100114","article-title":"Cutaneous burns from CS incapacitant spray","volume":"41","author":"Southward","year":"2001","journal-title":"Med Sci Law"},{"key":"10.1124\/jpet.123.001666_bib54","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00204-016-1873-x","article-title":"N-acetyl-L-cysteine inhibits sulfur mustard-induced and TRPA1-dependent calcium influx","volume":"91","author":"Stenger","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1124\/jpet.123.001666_bib55","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00204-014-1414-4","article-title":"Activation of the chemosensing transient receptor potential channel A1 (TRPA1) by alkylating agents","volume":"89","author":"Stenger","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.1124\/jpet.123.001666_bib56","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1038\/s41598-017-07651-5","article-title":"Involvement of transient receptor potential cation channel member A1 activation in the irritation and pain response elicited by skin-lightening reagent hydroquinone","volume":"7","author":"Tai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.123.001666_bib57","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.00005.2019","article-title":"Mammalian transient receptor potential TRPA1 channels: from structure to disease","volume":"100","author":"Talavera","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.123.001666_bib58","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1021\/acs.jmedchem.0c02023","article-title":"Tetrahydrofuran-based transient receptor potential ankyrin 1 (TRPA1) antagonists: ligand-based discovery, activity in a rodent asthma model, and mechanism-of-action via cryogenic electron microscopy","volume":"64","author":"Terrett","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001666_bib59","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1186\/s12889-021-10859-w","article-title":"Health issues and healthcare utilization among adults who reported exposure to tear gas during 2020 Portland (OR) protests: a cross-sectional survey","volume":"21","author":"Torgrimson-Ojerio","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1124\/jpet.123.001666_bib60","first-page":"4809","article-title":"Withdrawn: the novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs","volume":"177","author":"van den Berg","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001666_bib61","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1365-2230.2001.00806.x","article-title":"Severe cutaneous reaction to CS gas","volume":"26","author":"Varma","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1124\/jpet.123.001666_bib62","first-page":"83","article-title":"Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I\/II Committee","volume":"5","author":"Vasey","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.123.001666_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jemermed.2005.01.002","article-title":"Prevention of CS \u201ctear gas\u201d eye and skin effects and active decontamination with Diphoterine: preliminary studies in 5 French gendarmes","volume":"29","author":"Viala","year":"2005","journal-title":"J Emerg Med"},{"key":"10.1124\/jpet.123.001666_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-1873.2005.00585.x","article-title":"Unintended cutaneous reactions to CS spray","volume":"53","author":"Watson","year":"2005","journal-title":"Contact Dermat"},{"key":"10.1124\/jpet.123.001666_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282569","article-title":"Diisocyanates influence models of atopic dermatitis through direct activation of TRPA1","volume":"18","author":"Yadav","year":"2023","journal-title":"pLoS One"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:22:08Z","timestamp":1743200528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524171923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0022356524171923"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001666","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Inhibition of Transient Receptor Potential Ion Channel Ankyrin 1 Counteracts 2-Chlorobenzalmalononitrile Tear Gas Agent\u2013Induced Cutaneous Injuries","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The Author(s)","name":"copyright","label":"Copyright"}]}}